Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex & ORCID
How has Ujjala Ghoshal's publication output changed over time?
ScholarIQpublication output · 2004–2021
Output grew0% over the shown period — from 1 works in 2004 to 1 in 2021.
1
1
1
1
1
1
1
2
1
200420062012201520162017201920202021
What are the most-cited papers on Ujjala Ghoshal?
ScholarIQmost cited works
Infection with cytomegalovirus in patients with inflammatory bowel disease: prevalence, clinical significance and outcome
Janak Kishore, Ujjala Ghoshal, Uday C. Ghoshal, Narendra Krishnani, Sanjay Kumar, Manisha Singh, A Ayyagarí
S154078021. 2004234 Citations
Small Intestinal Bacterial Overgrowth and Irritable Bowel Syndrome: A Bridge between Functional Organic Dichotomy
Uday C. Ghoshal, Uday C. Ghoshal, Ratnakar Shukla, Ujjala Ghoshal, Ujjala Ghoshal
Gut and Liver. 2017204 CitationsOPEN ACCESS
Coronavirus Disease Pandemic (COVID-19): Challenges and a Global Perspective
Yashpal Singh Malik, Naveen Kumar, Shubhankar Sircar, Rahul Kaushik, Sudipta Bhat, Kuldeep Dhama, Parakriti Gupta, Kapil Goyal, Mini P. Singh, Ujjala Ghoshal, Mohamed E. El Zowalaty, VinodhKumar O. R, Mohd Iqbal Yatoo, Ruchi Tiwari, Mamta Pathak, Shailesh Kumar Patel, Ranjit Sah, Alfonso J. Rodríguez‐Morales, Balasubramanian Ganesh, Prashant Kumar, Raj Kumar Singh
S4210239906. 2020161 CitationsOPEN ACCESS
Fecal Microbiota in Patients with Irritable Bowel Syndrome Compared with Healthy Controls Using Real-Time Polymerase Chain Reaction: An Evidence of Dysbiosis
Ratnakar Shukla, Ujjala Ghoshal, Ujjala Ghoshal, Tapan N. Dhole, Uday C. Ghoshal, Uday C. Ghoshal
Digestive Diseases and Sciences. 2015155 Citations
The Gut Microbiota and Irritable Bowel Syndrome: Friend or Foe?
Uday C. Ghoshal, Uday C. Ghoshal, Ratnakar Shukla, Ujjala Ghoshal, Ujjala Ghoshal, Kok‐Ann Gwee, Siew C. Ng, Eamonn M.M. Quigley
S92596744. 2012145 CitationsOPEN ACCESS
Related on ScholarIQ
All India Institute of Medical Sciences
Institution
Infection with cytomegalovirus in patients with inflammatory bowel disease: prevalence, clinical significance and outcome
Paper
Small Intestinal Bacterial Overgrowth and Irritable Bowel Syndrome: A Bridge between Functional Organic Dichotomy
Paper
Coronavirus Disease Pandemic (COVID-19): Challenges and a Global Perspective
Paper
Fecal Microbiota in Patients with Irritable Bowel Syndrome Compared with Healthy Controls Using Real-Time Polymerase Chain Reaction: An Evidence of Dysbiosis
Paper
The Gut Microbiota and Irritable Bowel Syndrome: Friend or Foe?
Paper